BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 12124979)

  • 1. Evaluation of angiogenesis and side effects in ischemic rabbit hindlimbs after intramuscular injection of adenoviral vectors encoding VEGF and LacZ.
    Vajanto I; Rissanen TT; Rutanen J; Hiltunen MO; Tuomisto TT; Arve K; Närvänen O; Manninen H; Räsänen H; Hippeläinen M; Alhava E; Ylä-Herttuala S
    J Gene Med; 2002; 4(4):371-80. PubMed ID: 12124979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart.
    Rutanen J; Rissanen TT; Markkanen JE; Gruchala M; Silvennoinen P; Kivelä A; Hedman A; Hedman M; Heikura T; Ordén MR; Stacker SA; Achen MG; Hartikainen J; Ylä-Herttuala S
    Circulation; 2004 Mar; 109(8):1029-35. PubMed ID: 14967735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of VEGF-A induces neovascularization and increased vascular leakage in rabbit eye after intravitreal adenoviral gene transfer.
    Kinnunen K; Korpisalo P; Rissanen TT; Heikura T; Viita H; Uusitalo H; Ylä-Herttuala S
    Acta Physiol (Oxf); 2006 Aug; 187(4):447-57. PubMed ID: 16866776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor 4 induces vascular permeability, angiogenesis and arteriogenesis in a rabbit hindlimb ischemia model.
    Rissanen TT; Markkanen JE; Arve K; Rutanen J; Kettunen MI; Vajanto I; Jauhiainen S; Cashion L; Gruchala M; Närvänen O; Taipale P; Kauppinen RA; Rubanyi GM; Ylä-Herttuala S
    FASEB J; 2003 Jan; 17(1):100-2. PubMed ID: 12475908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of acute limb ischemia by intramuscular injection of vascular endothelial growth factor gene.
    Tsurumi Y; Kearney M; Chen D; Silver M; Takeshita S; Yang J; Symes JF; Isner JM
    Circulation; 1997 Nov; 96(9 Suppl):II-382-8. PubMed ID: 9386128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular, but not direct, adenoviral delivery of vascular endothelial growth factor results in improved left ventricular function and neovascularization in dilated ischemic cardiomyopathy.
    Askari A; Unzek S; Goldman CK; Ellis SG; Thomas JD; DiCorleto PE; Topol EJ; Penn MS
    J Am Coll Cardiol; 2004 May; 43(10):1908-14. PubMed ID: 15145120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic angiogenesis for ischemic syndromes.
    Weisz A; Koren B; Fischer L; Lewis BS; Flugelman MY
    Isr Med Assoc J; 2000 Jul; 2 Suppl():52-7. PubMed ID: 10909418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT).
    Hedman M; Hartikainen J; Syvänne M; Stjernvall J; Hedman A; Kivelä A; Vanninen E; Mussalo H; Kauppila E; Simula S; Närvänen O; Rantala A; Peuhkurinen K; Nieminen MS; Laakso M; Ylä-Herttuala S
    Circulation; 2003 Jun; 107(21):2677-83. PubMed ID: 12742981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene transfer of a soluble receptor of VEGF inhibits the growth of experimental eyelid malignant melanoma.
    Shiose S; Sakamoto T; Yoshikawa H; Hata Y; Kawano Y; Ishibashi T; Inomata H; Takayama K; Ueno H
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2395-403. PubMed ID: 10937546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor stimulates angiogenesis without improving collateral blood flow following hindlimb ischemia in rabbits.
    Hershey JC; Baskin EP; Corcoran HA; Bett A; Dougherty NM; Gilberto DB; Mao X; Thomas KA; Cook JJ
    Heart Vessels; 2003 Jul; 18(3):142-9. PubMed ID: 12955430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capillary enlargement, not sprouting angiogenesis, determines beneficial therapeutic effects and side effects of angiogenic gene therapy.
    Korpisalo P; Hytönen JP; Laitinen JT; Laidinen S; Parviainen H; Karvinen H; Siponen J; Marjomäki V; Vajanto I; Rissanen TT; Ylä-Herttuala S
    Eur Heart J; 2011 Jul; 32(13):1664-72. PubMed ID: 21138938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adeno-associated viral vector-mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heart.
    Su H; Lu R; Kan YW
    Proc Natl Acad Sci U S A; 2000 Dec; 97(25):13801-6. PubMed ID: 11095751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis is confined to the transient period of VEGF expression that follows adenoviral gene delivery to ischemic muscle.
    Gounis MJ; Spiga MG; Graham RM; Wilson A; Haliko S; Lieber BB; Wakhloo AK; Webster KA
    Gene Ther; 2005 May; 12(9):762-71. PubMed ID: 15772688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusion.
    Mack CA; Magovern CJ; Budenbender KT; Patel SR; Schwarz EA; Zanzonico P; Ferris B; Sanborn T; Isom P; Ferris B; Sanborn T; Isom OW; Crystal RG; Rosengart TK
    J Vasc Surg; 1998 Apr; 27(4):699-709. PubMed ID: 9576084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood flow remodels growing vasculature during vascular endothelial growth factor gene therapy and determines between capillary arterialization and sprouting angiogenesis.
    Rissanen TT; Korpisalo P; Markkanen JE; Liimatainen T; Ordén MR; Kholová I; de Goede A; Heikura T; Gröhn OH; Ylä-Herttuala S
    Circulation; 2005 Dec; 112(25):3937-46. PubMed ID: 16344386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of angiogenesis by cationic lipid-mediated VEGF165 gene transfer in the rabbit ischemic hindlimb model.
    Gowdak LH; Poliakova L; Li Z; Grove R; Lakatta EG; Talan M
    J Vasc Surg; 2000 Aug; 32(2):343-52. PubMed ID: 10917995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional Angiogenesis with Vascular Endothelial Growth Factor (VEGF) in peripheral arterial disease: Design of the RAVE trial.
    Rajagopalan S; Mohler E; Lederman RJ; Saucedo J; Mendelsohn FO; Olin J; Blebea J; Goldman C; Trachtenberg JD; Pressler M; Rasmussen H; Annex BH; Hirsch AT;
    Am Heart J; 2003 Jun; 145(6):1114-8. PubMed ID: 12796772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Direct intramuscular injection of pSV-VEGF(165) augments capillaries formation in a rabbit model of hindlimb ischemia].
    Zhao Y; Shi Y; He T; Zhang H; Chen S; Zhang B
    Zhonghua Wai Ke Za Zhi; 1999 Apr; 37(4):211-3. PubMed ID: 11829821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication.
    Rajagopalan S; Mohler ER; Lederman RJ; Mendelsohn FO; Saucedo JF; Goldman CK; Blebea J; Macko J; Kessler PD; Rasmussen HS; Annex BH
    Circulation; 2003 Oct; 108(16):1933-8. PubMed ID: 14504183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses.
    Rissanen TT; Markkanen JE; Gruchala M; Heikura T; Puranen A; Kettunen MI; Kholová I; Kauppinen RA; Achen MG; Stacker SA; Alitalo K; Ylä-Herttuala S
    Circ Res; 2003 May; 92(10):1098-106. PubMed ID: 12714562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.